Table 1.
Item | Reference range | Treatment1 | SEM2 | |||
---|---|---|---|---|---|---|
CT | FP | FSE | SE | |||
Creatinine, mg/dL | 0.5–1.5 | 0.6 | 0.5 | 0.5 | 0.5 | 0.05 |
Blood urea nitrogen, mg/dL | 6–30 | 12.5 | 10.6 | 10.5 | 11.7 | 1.03 |
Total protein, g/dL | 5.1–7.0 | 6.0 | 6.1 | 6.0 | 6.0 | 0.13 |
Albumin, g/dL | 2.5–3.8 | 3.3 | 3.4 | 3.3 | 3.3 | 0.08 |
Globulin, g/dL | 2.7–4.4 | 2.8 | 2.7 | 2.7 | 2.7 | 0.09 |
Calcium, mg/dL | 7.6–11.4 | 10.1 | 10.1 | 10.1 | 10.1 | 0.10 |
Phosphorus, mg/dL | 2.7–5.2 | 3.9 | 4.0 | 3.9 | 3.9 | 0.18 |
Sodium, mmol/L | 141–152 | 144.6 | 145.1 | 144.7 | 144.6 | 0.53 |
Potassium, mmol/L | 3.9–5.5 | 4.5 | 4.5 | 4.3 | 4.3 | 0.10 |
Sodium/potassium ratio | 28–36 | 32.6 | 32.6 | 33.6 | 33.9 | 0.77 |
Chloride, mmol/L | 107–118 | 109.5 | 110.0 | 110.2 | 110.2 | 0.76 |
Glucose, mg/dL | 68–126 | 90.2 | 90.4 | 92.2 | 90.2 | 2.13 |
Alkaline phosphatase total, U/L | 7–92 | 38.9 | 45.5 | 47.0 | 40.5 | 7.10 |
Corticosteroid-induced alkaline phosphatase, U/L | 0–40 | 11.1 | 14.1 | 15.0 | 12.4 | 4.83 |
Alanine aminotransferase, U/L | 8–65 | 22.4 | 23.0 | 22.6 | 25.7 | 2.34 |
Gamma-glutamyl transferase, U/L | 0–7 | 3.4 | 3.9 | 3.5 | 3.1 | 0.30 |
Total bilirubin, mg/dL | 0.1–0.3 | 0.2 | 0.2 | 0.2 | 0.2 | 0.02 |
Creatine kinase, U/L | 26–310 | 96.2 | 112.1 | 90.7 | 102.6 | 15.36 |
Cholesterol total, mg/dL | 129–297 | 229.6 | 231.1 | 240.5 | 224.0 | 17.78 |
Triglycerides, mg/dL | 35–154 | 70.9 | 82.9 | 71.9 | 60.7 | 9.21 |
Bicarbonate (TCO2), mmol/L | 16–24 | 20.9 | 19.7 | 20.4 | 20.9 | 0.44 |
Anion gap | 8–25 | 18.7 | 19.9 | 18.6 | 18.0 | 0.81 |
1CT = Control; FP = fiber and prebiotic blend; SE = saccharin and eugenol additive; FSE = fiber and prebiotic blend + saccharin and eugenol additive.
2Standard error of the mean.